
|Articles|February 5, 2004
Testosterone replacement therapy not linked to prostate cancer, analysis finds
There is no causal relationship between testosterone replacement and prostate cancer or heart disease risk, according to a retrospective analysis by researchers at Beth Israel Deaconess Medical Center, published last week in The New England Journal of Medicine (2004; 350:482-92).
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Elizabeth Nally, MBBS, on decision regret and toxicity perception with adjuvant pembrolizumab
2
Neil Baum, MD, and Abraham Morgentaler, MD, discuss the history of testosterone and prostate cancer
3
Optimizing care for men with overactive bladder, with Keith Xavier, MD
4
The UroOnc Minute: Navigating BCG Maintenance Therapy in NMIBC, With Mark D. Tyson, II, MD, MPH
5






